Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 286
About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Advertise Login 
Year : 2019  |  Volume : 8  |  Issue : 3  |  Page : 186-188

Neonatal thrombosis after antenatal treatment of neonatal alloimmune thrombocytopenia with intravenous immunoglobulin

1 Division of Pediatric Cancer and Blood Disorders; Department of Pediatrics, Atrium Health, Levine Children's Hospital, Charlotte, NC, USA
2 Department of Pediatrics; Division of Neonatology, Atrium Health, Levine Children's Hospital, Charlotte, NC, USA

Correspondence Address:
Dr. Ashley R. P Hinson
1001 Blythe Blvd., MCP Suite 601, Charlotte, NC 28203
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jcn.JCN_44_19

Rights and Permissions

Neonatal alloimmune thrombocytopenia (NAIT) may lead to serious complications, including perinatal intracranial hemorrhage and death. Mothers with a history of previously affected pregnancies should receive antenatal treatment with intravenous immunoglobulin (IVIG), which can be associated with toxicities including thrombosis. An infant born to a mother treated with IVIG and steroids was diagnosed with an inferior vena cava thrombus shortly after birth, was anticoagulated and recovered. Thus, this side effect can be seen, and should be considered, in infants of NAIT-affected pregnancies treated with IVIG.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
  Search Pubmed for
  Search in Google Scholar for
Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded89    
    Comments [Add]    
    Cited by others 1    

Recommend this journal